Service Details

National Institute of Mental Health: Pediatric and Developmental Neuropsychiatry Branch
10 Center Drive
MSC 1255
Bethesda, MD
20892-1255
Tel: 301-435-6652 or 301-496-5323 		Email
Web Page

If your child or teen (ages 7-17) is suffering from Obsessive-Compulsive Disorder (OCD) he or she may be able to participate in a research study at the National Institute of Mental Health (NIMH). We are investigating the medication riluzole.

Children and adolescents with 1) both Autism Spectrum Disorder and OCD or 2) a primary diagnosis of OCD may be eligible. Participants will be randomized to either riluzole or placebo (pill with no active ingredient) for 12 weeks. At the end of 12 weeks, all participants will have the option of taking riluzole (no chance of placebo). A comprehensive psychiatric and medical evaluation and follow-up visits approximately monthly for 6 months, and at 9 and 12 months, are included. There is no cost to participate. Travel assistance may be provided.

For further information please call 301-435-6652 or 301-496-5323 (Lorraine Lougee, LCSW-C) or email OCDNIMH@intra.nimh.nih.gov .
National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services.

Support Types:
- Research

 Ages Supported:
- 1-5 Grade
- 6-8 Grade
- 9-10 Grade
- 11-12 Grade

Ratings and Comments

Here is what people are saying about this service


This service provider has not yet been rated, Be the first to rate it.